semaglutide and aging aging: New study finds benefits beyond weight loss GLP-1s show signs of slowing

As more patients with breast cancer inquire about using GLP-1 receptor agonists to manage treatment-related weight gain, clinicians must look closely at long-term safety and survival data

1.) Screen those at risk for presymptomatic type 1 diabetes and those with type 1 phenotypic risk (younger age, ketoacidosis, etc.) by testing autoantibodies to insulin, GAD, islet antigen 2, ZnT8 2.) For Type 2 diabetes, screen everyone starting at age 35, but screen people with prediabetes yearly and those with GDM every 1-3 years

[31] One fatality has been confirmed since 1930, on February 16, 2024, [35] and the rare fatalities recorded before 1930 occurred in adults who were intoxicated by alcohol or had mismanaged the treatment of the bite

B.ManjunathaB.KundapurR